Overview

Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To demonstrate that the combination formulation of Moxifloxacin/Dexamethasone Eye Drop is effective and safe for the prevention of postoperative inflammation as a consequence of cataract extraction surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ophthalmic Solutions
Tetrahydrozoline